124 related articles for article (PubMed ID: 28238757)
1. Variations in Preoperative Use of Bone Scan Among Medicare Beneficiaries Undergoing Radical Cystectomy.
Turner RM; Yabes JG; Davies BJ; Heron DE; Jacobs BL
Urology; 2017 May; 103():84-90. PubMed ID: 28238757
[TBL] [Abstract][Full Text] [Related]
2. Increasing use of positron emission tomography among medicare beneficiaries undergoing radical cystectomy.
Maganty A; Turner RM; Yabes JG; Heron DE; Gingrich JR; Davies BJ; Jacobs BL
Eur J Cancer Care (Engl); 2020 Jul; 29(4):e13230. PubMed ID: 32026559
[TBL] [Abstract][Full Text] [Related]
3. Determinants of radical cystectomy operative time.
Filson CP; Tan HJ; Chamie K; Laviana AA; Hu JC
Urol Oncol; 2016 Oct; 34(10):431.e17-24. PubMed ID: 27372282
[TBL] [Abstract][Full Text] [Related]
4. Adherence to surveillance guidelines after radical cystectomy: a population-based analysis.
Ehdaie B; Atoria CL; Lowrance WT; Herr HW; Bochner BH; Donat SM; Dalbagni G; Elkin EB
Urol Oncol; 2014 Aug; 32(6):779-84. PubMed ID: 24935876
[TBL] [Abstract][Full Text] [Related]
5. Health Related Quality of Life Following Radical Cystectomy: Comparative Analysis from the Medicare Health Outcomes Survey.
Winters BR; Wright JL; Holt SK; Dash A; Gore JL; Schade GR
J Urol; 2018 Mar; 199(3):669-675. PubMed ID: 28882404
[TBL] [Abstract][Full Text] [Related]
6. Volume outcomes of cystectomy--is it the surgeon or the setting?
Morgan TM; Barocas DA; Keegan KA; Cookson MS; Chang SS; Ni S; Clark PE; Smith JA; Penson DF
J Urol; 2012 Dec; 188(6):2139-44. PubMed ID: 23083864
[TBL] [Abstract][Full Text] [Related]
7. Use of radical cystectomy as initial therapy for the treatment of high-grade T1 urothelial carcinoma of the bladder: a SEER database analysis.
Canter D; Egleston B; Wong YN; Smaldone MC; Simhan J; Greenberg RE; Uzzo RG; Kutikov A
Urol Oncol; 2013 Aug; 31(6):866-70. PubMed ID: 21906968
[TBL] [Abstract][Full Text] [Related]
8. Volume, process of care, and operative mortality for cystectomy for bladder cancer.
Hollenbeck BK; Wei Y; Birkmeyer JD
Urology; 2007 May; 69(5):871-5. PubMed ID: 17482924
[TBL] [Abstract][Full Text] [Related]
9. Assessing trends in urinary diversion after radical cystectomy for bladder cancer in the United States.
Lin-Brande M; Nazemi A; Pearce SM; Thompson ER; Ashrafi AN; Djaladat H; Schuckman A; Daneshmand S
Urol Oncol; 2019 Mar; 37(3):180.e1-180.e9. PubMed ID: 30482434
[TBL] [Abstract][Full Text] [Related]
10. Factors influencing aggressive therapy for bladder cancer: an analysis of data from the SEER program.
Konety BR; Joslyn SA
J Urol; 2003 Nov; 170(5):1765-71. PubMed ID: 14532772
[TBL] [Abstract][Full Text] [Related]
11. Preoperative Incidence of Deep Venous Thrombosis in Patients With Bladder Cancer Undergoing Radical Cystectomy.
Schomburg JL; Krishna S; Cotter KJ; Soubra A; Rao A; Konety BR
Urology; 2018 Jun; 116():120-124. PubMed ID: 29551621
[TBL] [Abstract][Full Text] [Related]
12. [(18)F]Fluorodeoxyglucose - positron emission tomography/computed tomography improves staging in patients with high-risk muscle-invasive bladder cancer scheduled for radical cystectomy.
Kollberg P; Almquist H; Bläckberg M; Cronberg C; Garpered S; Gudjonsson S; Kleist J; Lyttkens K; Patschan O; Liedberg F
Scand J Urol; 2015; 49(4):296-301. PubMed ID: 25623843
[TBL] [Abstract][Full Text] [Related]
13. Regionalization of radical cystectomy in the United States.
Anderson CB; Gennarelli R; Herr HW; Elkin EB
Urol Oncol; 2017 Aug; 35(8):528.e7-528.e13. PubMed ID: 28412027
[TBL] [Abstract][Full Text] [Related]
14. Comparing Survival Outcomes and Costs Associated With Radical Cystectomy and Trimodal Therapy for Older Adults With Muscle-Invasive Bladder Cancer.
Williams SB; Shan Y; Jazzar U; Mehta HB; Baillargeon JG; Huo J; Senagore AJ; Orihuela E; Tyler DS; Swanson TA; Kamat AM
JAMA Surg; 2018 Oct; 153(10):881-889. PubMed ID: 29955780
[TBL] [Abstract][Full Text] [Related]
15. Role of routine computed tomography scan in the oncological follow up of patients treated by radical cystectomy for bladder cancer.
Alimi Q; Verhoest G; Kammerer-Jacquet SF; Mathieu R; Rioux-Leclercq N; Manunta A; Laguerre B; Guille F; Bensalah K; Peyronnet B
Int J Urol; 2016 Oct; 23(10):840-846. PubMed ID: 27416787
[TBL] [Abstract][Full Text] [Related]
16. Utilisation of preoperative imaging for muscle-invasive bladder cancer: a population-based study.
McInnes MD; Siemens DR; Mackillop WJ; Peng Y; Wei S; Schieda N; Booth CM
BJU Int; 2016 Mar; 117(3):430-8. PubMed ID: 25561020
[TBL] [Abstract][Full Text] [Related]
17. Contemporary 90-day mortality rates after radical cystectomy in the elderly.
Schiffmann J; Gandaglia G; Larcher A; Sun M; Tian Z; Shariat SF; McCormack M; Valiquette L; Montorsi F; Graefen M; Saad F; Karakiewicz PI
Eur J Surg Oncol; 2014 Dec; 40(12):1738-45. PubMed ID: 25454826
[TBL] [Abstract][Full Text] [Related]
18. Impact of malpractice caps on use and outcomes of radical cystectomy for bladder cancer: data from the surveillance, epidemiology, and end results program.
Konety BR; Dhawan V; Allareddy V; Joslyn SA
J Urol; 2005 Jun; 173(6):2085-9. PubMed ID: 15879848
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of routine pre-cystectomy bone scans in patients with muscle-invasive bladder cancer.
Braendengen M; Winderen M; Fosså SD
Br J Urol; 1996 Jan; 77(1):36-40. PubMed ID: 8653315
[TBL] [Abstract][Full Text] [Related]
20. A population based assessment of perioperative mortality after cystectomy for bladder cancer.
Isbarn H; Jeldres C; Zini L; Perrotte P; Baillargeon-Gagne S; Capitanio U; Shariat SF; Arjane P; Saad F; McCormack M; Valiquette L; Peloquin F; Duclos A; Montorsi F; Graefen M; Karakiewicz PI
J Urol; 2009 Jul; 182(1):70-7. PubMed ID: 19447427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
